Company: CDLX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001666071-25-000034
Chunk: 114

Company: Cardlytics, Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 8
Chunk 114
---
DeficitTotalCommon StockSharesAmountBalance – December 31, 202339,728 $9 $1,243,594 $2,467 $(1,111,272)$134,798 Exercise of common stock options6 — 15 — — 15 Stock-based compensation— — 45,370 — — 45,370 Issuance of restricted stock3,503 1 — — — 1 Issuance of common stock, net of issuance cost3,592 — 27,451 — — 27,451 Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below)3,908 — 48,151 — — 48,151 Issuance of common stock pursuant to the 2018 ESPP (as defined below)520 — 2,262 — — 2,262 Termination of capped calls related to 2020 Convertible Senior Notes— — 115 — — 115 Other comprehensive income— — — 1,134 — 1,134 Net loss— — — — (189,304)(189,304)Balance – December 31, 202451,257 $10 $1,366,958 $3,601 $(1,300,576)$69,993 

Year Ended December 31, 2023:

AdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (loss)AccumulatedDeficitTotalCommon StockSharesAmountBalance – December 31, 202233,477 $9 $1,182,568 $5,598 $(976,570)$211,605 Exercise of common stock options10 — 54 — — 54 Stock-based compensation— — 43,466 — — 43,466 Issuance of restricted stock2,930 — — — — — Issuance of common stock2,755 — 15,171 — — 15,171 Issuance of common stock under the ESPP556 — 2,335 — — 2,335 Other comprehensive loss— — — (3,131)— (3,131)Net loss— — — —